ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685833; 2) Community: the network communities that were significantly associated with the response to NSC 685833; 3) Molecule: the relationships between components within communities and NSC 685833; 4) MDR: the compounds that were significantly associated with the NSC 685833.

NSC Compound Enrichment Correlation
NSC 737077 Null 0.0248868750898601 0.27816783
NSC 737147 2-(4-Chloroanilino)-N'-[(4-acetylaminophenyl)sulphonyl]nicotino hydrazide 0.0248868750898601 0.19118958
NSC 745943 Null 0.0248868750898601 -0.08975393
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0248868750898601 0.41704382
NSC 748870 Null 0.0248868750898601 0.33058993
NSC 751500 Null 0.0248868750898601 0.038603259
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0248868750898601 0.22583376
NSC 77039 Null 0.0248868750898601 0.36637248
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0248868750898601 0.58739658
NSC 87500 Solacongestidine 0.0248868750898601 0.42343748
Total:144  Current:100    [First] [Prev] [Next] [Last]